PCOS and Pregnancy After IVF: When to Ask About Glucose Screening

A normal fasting glucose alone does not answer every question about glucose tolerance. International PCOS guidance emphasises the oral glucose tolerance test (OGTT) as an accurate way to assess glycaemic status, particularly when planning pregnancy. Bring previous fasting glucose, HbA1c and OGTT results, along with their dates and whether medicines were being taken. A value from years earlier may not describe current health. Screening decisions should include body weight, family history, other medical conditions and whether the obstetric clinician already has a defined antenatal diabetes pathway.

PCOS recommendations support offering an OGTT before conception or infertility treatment and, if that was not completed, considering it at the first prenatal visit. They also advise testing at the routine gestational-diabetes assessment window around 24–28 weeks. Exact local implementation and medical exceptions should be clarified by the obstetric team. An IVF calendar does not replace the estimated gestational age used for antenatal appointments. Ask who orders the test, explains preparation and follows up a result outside the laboratory reference range.

Some people with PCOS use metformin before conception, while others use it for a different metabolic indication. Whether to continue, alter or stop medication in pregnancy requires an individual medical decision. Do not assume metformin removes the need for testing or guarantees prevention of gestational diabetes. The fertility specialist and obstetrician should reconcile progesterone, other fertility medicines, any diabetes therapy and supplements. If the patient experiences significant nausea or cannot complete an oral test, the clinician should decide what validated alternative or rescheduling plan is appropriate.

A glucose result is information for planning; it is not a judgment on personal habits or success in becoming pregnant. If the result suggests gestational diabetes, the antenatal team may arrange dietary counselling, self-monitoring, medicine when necessary and appropriate fetal surveillance. The plan depends on the full clinical picture and available local services. Patients should not restrict food, skip necessary treatment or attempt unverified herbal remedies to alter a test. Explain practical needs such as work schedules and access to appointments so the plan is actually sustainable.

At a confirmed pregnancy, request a written record of PCOS diagnosis, glucose tests, current medicines, blood-pressure history and anticipated obstetric review. Selected home blood collection may be possible where a verified service exists, but an OGTT has specific laboratory handling and timing requirements that should not be assumed available at home. Early pregnancy ultrasound and medical reviews when indicated remain facility-based. HomeIVF can support doctor-led coordination, but the antenatal clinician must own the glucose-screening schedule and results.

Someone with PCOS may focus intensely on embryo implantation and feel that metabolic health is no longer relevant once beta-hCG rises. Yet glucose regulation, blood pressure, weight trends and other individual factors still matter during pregnancy. Ask the obstetric clinician whether glucose testing should be done before conception or early in pregnancy and how later pregnancy screening will be scheduled. Recommendations differ depending on diabetes history, medicines, body mass index and local protocols. A patient who used metformin before treatment should not automatically continue or stop it; the obstetric and prescribing clinicians should review its indication. Avoid assuming that a pregnancy after IVF requires the same monitoring for everyone, or that PCOS alone determines whether gestational diabetes will occur. The purpose of screening is to identify actionable concerns, not to assign blame.

Create a written handover from the fertility doctor to the obstetrician with current medicines, any previous abnormal glucose results, pregnancy dating method and relevant complications. Ask who will give the next prescription and explain the timing of glucose tests, blood-pressure review and routine antenatal scans. Home blood collection may be possible for selected tests in covered areas, but a formal glucose tolerance test can have special preparation, timing and sampling requirements that may not be appropriate for every home collection pathway. Verify the laboratory arrangement before choosing convenience over accuracy. If marked thirst, persistent vomiting, fainting or other concerning symptoms occur, seek clinical assessment rather than using a home glucose reading to diagnose the cause. Patients benefit from fewer avoidable appointments only when the clinically necessary ones are preserved and clearly explained.

The pregnancy handover should include metabolic monitoring when appropriate for individual PCOS history. HomeIVF describes doctor-led fertility care that can coordinate appropriate consultations and selected monitoring without unnecessary clinic journeys. Teleconsultation, suitable home blood collection and professionally supported prescribed injections may be available only after the patient’s medical suitability and local service coverage are verified. Necessary ultrasound, egg retrieval, sperm preparation, embryo culture, embryo storage and embryo transfer take place in appropriate facilities. No particular clinician, partner centre, visit time, price or treatment outcome is promised.

• Past tests: Bring the date and type of any OGTT, HbA1c or fasting glucose.
• Timing: Confirm whether an early test and 24–28-week screen are needed.
• Medicines: Reconcile metformin, progesterone and other prescriptions.
• Result owner: Identify who will contact you if the test is abnormal.
• Delivery setting: Verify whether a laboratory visit is required for the test.